Susquehanna International Group, LLP Cocrystal Pharma, Inc. Transaction History

Susquehanna International Group, LLP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.38 - $0.55 $6,129 - $8,870	-16,129 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$0.48 - $0.71 $7,741 - $11,451	16,129 New	16,129 $9,000
Q4 2018 Feb 14, 2019	SELL	$1.6 - $3.68 $16,651 - $38,297	-10,407 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$2.3 - $4.95 $23,936 - $51,514	10,407 New	10,407 $26,000

Ticker COCP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 8,122,420
Market Cap $21.3M
Description
Cocrystal Pharma, Inc., a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases. It employs structure-based technologies to create antiviral drugs primarily to treat hepatitis C virus (HCV), influenza virus, coronavirus, and norovirus infections. The company ...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.